Sign Up Today and Learn More About Ariceum Therapeutics Stock
Invest in or calculate the value of your shares in Ariceum Therapeutics or other pre-IPO companies through EquityZen's platform.
Ariceum Therapeutics Stock (ARTH)
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
About Ariceum Therapeutics Stock
Founded
2021
Industries
Software, Artificial Intelligence, Data and Analytics
Ariceum Therapeutics Press Mentions
Stay in the know about the latest news on Ariceum Therapeutics
U.S. FDA Grants Orphan Drug Designation to Ariceum Therap...
pharmiweb • Feb 07, 2025
Composition containing a somatostatin analogue for radiopharmaceutical use
patents • Feb 07, 2025
Composition containing somatostatin analogue for radiopharmaceutical use
patents • Feb 07, 2025
Alpha emitter labelled somatostatin receptor antagonists
patents • Feb 07, 2025
U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics' Proprietary Radiopharmaceutical Cancer Therapy
prnewswire • Feb 06, 2025
Ariceum Therapeutics Management
Leadership team at Ariceum Therapeutics
Board of Directors
Christoph Massner
Board Member
Per Samuelsson
Join now and verify your accreditation status to gain access to:
- Ariceum Therapeutics Current Valuation
- Ariceum Therapeutics Stock Price
- Ariceum Therapeutics Management
- Available deals in Ariceum Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ariceum Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Ariceum Therapeutics Revenue and Financials
- Ariceum Therapeutics Highlights
- Ariceum Therapeutics Business Model
- Ariceum Therapeutics Risk Factors
- Ariceum Therapeutics Research Report from SACRA Research
Trading Ariceum Therapeutics Stock
How to invest in Ariceum Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Ariceum Therapeutics through EquityZen funds. These investments are made available by existing Ariceum Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Ariceum Therapeutics stock?
Shareholders can sell their Ariceum Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
